+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Metabolomics Services Market - Global Forecast 2026-2032- Product Image
Metabolomics Services Market - Global Forecast 2026-2032- Product Image
Sale

Metabolomics Services Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6151674
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Metabolomics Services Market is projected to reach USD 1.34 Billion in 2026. It is expected to continue growing at a CAGR of 11.21%, reaching USD 2.53 Billion by 2032.

Metabolomics Services: Executive Overview

Metabolomics services support the measurement and interpretation of small-molecule profiles in biological systems. They are used across drug discovery, clinical research, nutrition, agriculture, environmental studies, and biomarker development. The field combines analytical platforms, sample preparation, bioinformatics, statistical analysis, and biological interpretation, making data quality and workflow integration central to research outcomes.

How Integrated Workflows Are Transforming Metabolomics

The landscape is shifting from stand-alone analytical testing toward integrated workflows that connect study design, sample management, mass spectrometry or nuclear magnetic resonance analysis, computational processing, and biological validation. Greater attention to standardized protocols, quality controls, reference materials, and interoperable data formats is improving comparability across studies. Demand is also moving toward translational applications, where metabolomic findings must be linked with genomics, proteomics, clinical records, and functional experiments.

Artificial Intelligence Is Accelerating Interpretation and Quality Control

Artificial intelligence is expanding the role of metabolomics services by supporting feature detection, compound annotation, spectral matching, dimensionality reduction, classification, pathway analysis, and anomaly detection. Machine-learning models can help prioritize biomarkers and identify complex relationships in high-dimensional datasets, but their value depends on representative training data, rigorous validation, transparent preprocessing, and control of batch effects. Human review remains important for biological interpretation, causal assessment, and decisions affecting clinical or regulatory use.

Regional Insights Across the Global Metabolomics Landscape

North America benefits from established biomedical research infrastructure, strong translational programs, and broad adoption of advanced analytical technologies. Europe emphasizes cross-border research collaboration, data governance, reproducibility, and integration with public research networks. Asia-Pacific is strengthening capabilities through expanding life-sciences research, technology investment, and pharmaceutical activity. Latin America is developing applications in health, agriculture, and biodiversity while navigating uneven access to specialized instrumentation. The Middle East is investing in research capacity and precision-health initiatives, and Africa is applying metabolomics to infectious disease, nutrition, agriculture, and population health, with infrastructure and specialist training remaining important priorities.

Group Insights: Collaboration, Standards, and Strategic Capacity

ASEAN economies are building regional research links and applying metabolomics to health, food, and agricultural questions. BRICS members bring diverse capabilities spanning large research systems, public-health priorities, agriculture, and industrial applications, while collaboration and data interoperability remain valuable. The European Union places strong emphasis on coordinated research, privacy-aware data management, and standardized methods. G7 members generally provide mature research ecosystems and advanced analytical expertise. GCC countries are developing precision-health and biomedical research capacity, while NATO members contribute extensive defense, health, and academic research networks in which secure data practices and interoperable workflows are relevant.

Country Insights: Diverse National Capabilities and Applications

Australia applies metabolomics across biomedical, environmental, agricultural, and marine research. Brazil uses it in health, food, agriculture, and biodiversity studies, while Canada combines strong academic, clinical, and biotechnology research capabilities. China is expanding analytical infrastructure and translational research; India is applying metabolomics to pharmaceuticals, disease research, agriculture, and nutrition. Japan and South Korea are recognized for advanced instrumentation, precision-health research, and technology development. In Europe, France, Germany, Italy, Spain, and the United Kingdom support applications across clinical research, pharmaceuticals, food science, and academic biology. Mexico is developing capabilities in public health, agriculture, and food research, while Russia maintains applications across biomedical, environmental, and agricultural research domains. The United States remains a major center for multidisciplinary metabolomics, with extensive links among academic, clinical, pharmaceutical, and technology organizations.

Priorities for Leaders Building Reliable Metabolomics Programs

Industry leaders should define analytical and biological objectives before selecting platforms or service partners, then establish requirements for sample handling, metadata, controls, replication, and reporting. Programs should favor transparent workflows that document preprocessing, compound identification confidence, statistical assumptions, and validation plans. Investments in shared data standards, secure infrastructure, staff training, and cross-disciplinary interpretation can improve reuse and reproducibility. Organizations should evaluate artificial-intelligence tools through independent validation and monitor model drift, bias, and explainability. Partnerships with clinical, computational, and domain specialists are especially important when findings may influence therapeutic development, diagnostics, or policy.

Methodology for a Rigorous Metabolomics Services Assessment

This executive summary uses a structured qualitative assessment of metabolomics-service applications, workflow developments, analytical requirements, artificial-intelligence use cases, and geographic research conditions. The analysis organizes evidence by region, economic and policy grouping, and country, while distinguishing established practices from emerging capabilities. It focuses on verifiable themes such as infrastructure, research priorities, standardization, data governance, and translational requirements. No market estimates, market sizing, market shares, or forecasts are used; conclusions should be tested against current primary literature, institutional documentation, regulatory materials, and validated technical performance data.

Conclusion: Build Metabolomics Around Reproducibility and Translation

Metabolomics services are becoming more valuable as research moves toward integrated, data-rich, and application-focused workflows. The strongest programs will combine analytical rigor with robust sample governance, interoperable data, validated computational methods, and domain-specific interpretation. Regional and national capabilities differ, but all stakeholders can improve outcomes by prioritizing reproducibility, transparent artificial-intelligence use, workforce development, and collaboration across biological, clinical, computational, and industrial disciplines.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Metabolomics Services Market, by Platform
7.1. Introduction
7.2. Capillary Electrophoresis Mass Spectrometry
7.3. Gas Chromatography Mass Spectrometry
7.4. Liquid Chromatography Mass Spectrometry
7.5. Nuclear Magnetic Resonance
8. Metabolomics Services Market, by Service Type
8.1. Introduction
8.2. Targeted Metabolomics
8.2.1. Biomarker Validation
8.2.2. Metabolite Quantification
8.3. Untargeted Metabolomics
8.3.1. Data Mining
8.3.2. De Novo Profiling
9. Metabolomics Services Market, by Sample Type
9.1. Introduction
9.2. Blood Samples
9.3. Urine Samples
9.4. Tissue Samples
9.5. Cell Culture Samples
9.6. Fecal Samples
9.7. Food & Plant Samples
10. Metabolomics Services Market, by Sample Source
10.1. Introduction
10.2. Human Samples
10.3. Animal Samples
10.4. Microbial Samples
10.5. Plant Samples
11. Metabolomics Services Market, by Application
11.1. Introduction
11.2. Clinical Diagnostics
11.3. Drug Discovery & Development
11.4. Environmental Analysis
11.5. Nutritional Research
12. Metabolomics Services Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Agricultural Sector
12.4. Clinical Laboratories
12.5. Food & Beverage Industry
12.6. Pharmaceutical & Biotechnology Companies
13. Metabolomics Services Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Metabolomics Services Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Metabolomics Services Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Agilent Technologies, Inc.
17.2. Biocrates Life Sciences AG
17.3. Biognosys AG
17.4. BioIVT, LLC
17.5. Bruker Corporation
17.6. Charles River Laboratories International, Inc.
17.7. Creative Proteomics, Inc.
17.8. Eurofins Scientific SE
17.9. Evotec SE
17.10. Human Metabolome Technologies, Inc.
17.11. LECO Corporation
17.12. Metabolon, Inc.
17.13. MRM Proteomics Inc.
17.14. Nightingale Health Ltd.
17.15. Q2 Solutions, LLC
17.16. Revvity, Inc.
17.17. SGS SA
17.18. Shanghai ChemPartner Co., Ltd.
17.19. Shimadzu Corporation
17.20. Thermo Fisher Scientific Inc.
17.21. Waters Corporation
17.22. Zora Biosciences Oy
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Metabolomics Services Market, Years Considered for the Study
FIGURE 2. Global Metabolomics Services Market, Research Design
FIGURE 3. Global Metabolomics Services Market, Research Framework
FIGURE 4. Global Metabolomics Services Market, Data Triangulation
FIGURE 5. Global Metabolomics Services Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Metabolomics Services Market Size, by Platform, 2025 vs 2032 (%)
FIGURE 7. Global Metabolomics Services Market Size, by Platform, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Metabolomics Services Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 9. Global Metabolomics Services Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Metabolomics Services Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Metabolomics Services Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Metabolomics Services Market Size, by Sample Source, 2025 vs 2032 (%)
FIGURE 13. Global Metabolomics Services Market Size, by Sample Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Metabolomics Services Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Metabolomics Services Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Metabolomics Services Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Metabolomics Services Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Metabolomics Services Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Metabolomics Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Metabolomics Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Metabolomics Services Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Metabolomics Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Metabolomics Services Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Metabolomics Services Market Segmentation & Coverage
TABLE 2. Global Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 3. Global Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 4. Global Capillary Electrophoresis Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Capillary Electrophoresis Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Capillary Electrophoresis Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Gas Chromatography Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Gas Chromatography Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Gas Chromatography Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Liquid Chromatography Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Liquid Chromatography Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Liquid Chromatography Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Nuclear Magnetic Resonance Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Nuclear Magnetic Resonance Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Nuclear Magnetic Resonance Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 17. Global Targeted Metabolomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Targeted Metabolomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Targeted Metabolomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Biomarker Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Biomarker Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Biomarker Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Metabolite Quantification Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Metabolite Quantification Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Metabolite Quantification Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Untargeted Metabolomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Untargeted Metabolomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Untargeted Metabolomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Data Mining Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Data Mining Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Data Mining Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global De Novo Profiling Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global De Novo Profiling Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global De Novo Profiling Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 36. Global Blood Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Blood Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Blood Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Urine Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Urine Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Urine Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Tissue Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Tissue Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Tissue Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Cell Culture Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Cell Culture Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Cell Culture Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Fecal Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Fecal Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Fecal Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Food & Plant Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Food & Plant Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Food & Plant Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 55. Global Human Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Human Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Human Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Animal Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Animal Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Animal Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Microbial Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Microbial Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Microbial Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Plant Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Plant Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Plant Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 68. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Drug Discovery & Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Drug Discovery & Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Drug Discovery & Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Environmental Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Environmental Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Environmental Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Nutritional Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Nutritional Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Nutritional Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Agricultural Sector Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Agricultural Sector Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Agricultural Sector Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Food & Beverage Industry Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Food & Beverage Industry Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Food & Beverage Industry Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Metabolomics Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Metabolomics Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. North America Metabolomics Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. North America Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 108. North America Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 109. North America Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 110. North America Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 111. North America Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 112. North America Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 113. North America Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. North America Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Latin America Metabolomics Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Latin America Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 117. Latin America Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 118. Latin America Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 119. Latin America Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 120. Latin America Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 121. Latin America Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 122. Latin America Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 123. Latin America Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Europe Metabolomics Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Europe Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 126. Europe Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 127. Europe Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 128. Europe Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 129. Europe Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 130. Europe Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 131. Europe Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. Europe Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Middle East Metabolomics Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Middle East Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 135. Middle East Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 136. Middle East Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 137. Middle East Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 138. Middle East Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 139. Middle East Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 140. Middle East Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. Middle East Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. Africa Metabolomics Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Africa Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 144. Africa Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 145. Africa Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 146. Africa Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 147. Africa Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 148. Africa Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 149. Africa Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Africa Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Global Metabolomics Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. ASEAN Metabolomics Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. ASEAN Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 154. ASEAN Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 155. ASEAN Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 156. ASEAN Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 157. ASEAN Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 158. ASEAN Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 159. ASEAN Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. ASEAN Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. GCC Metabolomics Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. GCC Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 163. GCC Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 164. GCC Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 165. GCC Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 166. GCC Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 167. GCC Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 168. GCC Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. GCC Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. European Union Metabolomics Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. European Union Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 172. European Union Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 173. European Union Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 174. European Union Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 175. European Union Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 176. European Union Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 177. European Union Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. European Union Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. BRICS Metabolomics Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. BRICS Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 181. BRICS Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 182. BRICS Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 183. BRICS Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 184. BRICS Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 185. BRICS Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 186. BRICS Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. BRICS Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. G7 Metabolomics Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. G7 Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 190. G7 Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 191. G7 Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 192. G7 Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 193. G7 Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 194. G7 Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 195. G7 Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. G7 Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. NATO Metabolomics Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. NATO Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 199. NATO Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 200. NATO Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 201. NATO Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 202. NATO Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 203. NATO Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 204. NATO Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. NATO Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Global Metabolomics Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 207. United States Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 208. United States Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 209. United States Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 210. United States Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 211. United States Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 212. United States Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 213. United States Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 214. United States Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. United States Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Canada Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 217. Canada Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 218. Canada Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 219. Canada Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 220. Canada Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 221. Canada Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 222. Canada Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 223. Canada Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. Canada Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Mexico Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 226. Mexico Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 227. Mexico Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 228. Mexico Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 229. Mexico Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 230. Mexico Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 231. Mexico Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 232. Mexico Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. Mexico Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Brazil Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 235. Brazil Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 236. Brazil Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 237. Brazil Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 238. Brazil Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 239. Brazil Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 240. Brazil Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 241. Brazil Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. Brazil Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. United Kingdom Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 244. United Kingdom Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 245. United Kingdom Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 246. United Kingdom Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 247. United Kingdom Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 248. United Kingdom Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 249. United Kingdom Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 250. United Kingdom Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. United Kingdom Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Germany Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 253. Germany Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 254. Germany Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 255. Germany Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 256. Germany Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 257. Germany Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 258. Germany Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 259. Germany Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. Germany Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. France Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 262. France Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 263. France Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 264. France Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 265. France Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 266. France Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 267. France Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 268. France Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. France Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Russia Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 271. Russia Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 272. Russia Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 273. Russia Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 274. Russia Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 275. Russia Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 276. Russia Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 277. Russia Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. Russia Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Italy Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 280. Italy Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 281. Italy Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 282. Italy Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 283. Italy Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 284. Italy Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 285. Italy Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 286. Italy Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. Italy Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 288. Spain Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 289. Spain Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 290. Spain Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 291. Spain Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 292. Spain Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 293. Spain Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 294. Spain Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 295. Spain Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 296. Spain Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. China Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 298. China Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 299. China Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 300. China Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 301. China Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 302. China Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 303. China Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 304. China Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 305. China Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. India Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 307. India Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 308. India Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 309. India Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 310. India Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 311. India Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 312. India Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 313. India Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 314. India Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 315. Japan Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 316. Japan Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 317. Japan Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 318. Japan Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 319. Japan Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 320. Japan Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 321. Japan Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 322. Japan Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 323. Japan Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 324. Australia Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 325. Australia Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 326. Australia Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 327. Australia Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 328. Australia Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 329. Australia Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 330. Australia Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 331. Australia Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 332. Australia Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 333. South Korea Metabolomics Services Market Size, 2017-2032 (USD Million)
TABLE 334. South Korea Metabolomics Services Market Size, by Platform, 2017-2032 (USD Million)
TABLE 335. South Korea Metabolomics Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 336. South Korea Metabolomics Services Market Size, by Targeted Metabolomics, 2017-2032 (USD Million)
TABLE 337. South Korea Metabolomics Services Market Size, by Untargeted Metabolomics, 2017-2032 (USD Million)
TABLE 338. South Korea Metabolomics Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 339. South Korea Metabolomics Services Market Size, by Sample Source, 2017-2032 (USD Million)
TABLE 340. South Korea Metabolomics Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 341. South Korea Metabolomics Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 342. Global Metabolomics Services Market Share, by Key Player, 2025
TABLE 343. Global Metabolomics Services Market, Key Experts

Companies Mentioned

  • Agilent Technologies, Inc.
  • Biocrates Life Sciences AG
  • Biognosys AG
  • BioIVT, LLC
  • Bruker Corporation
  • Charles River Laboratories International, Inc.
  • Creative Proteomics, Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • Human Metabolome Technologies, Inc.
  • LECO Corporation
  • Metabolon, Inc.
  • MRM Proteomics Inc.
  • Nightingale Health Ltd.
  • Q2 Solutions, LLC
  • Revvity, Inc.
  • SGS SA
  • Shanghai ChemPartner Co., Ltd.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • Zora Biosciences Oy

Related Topics

Related Reports

Untargeted Metabolomics Market - Global Forecast 2026-2032 - Product Image

Untargeted Metabolomics Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Metabolomics Market - Global Forecast 2026-2032 - Product Image

Metabolomics Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Metabolomics Services Market Report 2026 - Product Image

Metabolomics Services Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Metabolomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Metabolomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 116 Pages
  • Global
From
Metabolomics Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035) - Product Image

Metabolomics Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)

  • Report
  • 350 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.